These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25875733)

  • 21. A new factor X defect (factor X Padua 3): a compound heterozygous between true deficiency (Gly(380)-->Arg) and an abnormality (Ser(334)-->Pro).
    Vianello F; Lombardi AM; Boldrin C; Luni S; Girolami A
    Thromb Res; 2001 Nov; 104(4):257-64. PubMed ID: 11728527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic analysis of hereditary factor X deficiency in a French patient of Sri Lankan ancestry: in vitro expression study identified Gly366Ser substitution as the molecular basis of the dysfunctional factor X.
    Isshiki I; Favier R; Moriki T; Uchida T; Ishihara H; Van Dreden P; Murata M; Ikeda Y
    Blood Coagul Fibrinolysis; 2005 Jan; 16(1):9-16. PubMed ID: 15650540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inherited coagulation factor X deficiency caused by two novel mutations in factor X gene].
    Wang WB; Wang HL; Wang XF; Fu QH; Zhou RF; Xie S; Hu YQ; Wang ZY
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):519-22. PubMed ID: 15569527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular defect (Gla+14----Lys) and its functional consequences in a hereditary factor X deficiency (factor X "Vorarlberg").
    Watzke HH; Lechner K; Roberts HR; Reddy SV; Welsch DJ; Friedman P; Mahr G; Jagadeeswaran P; Monroe DM; High KA
    J Biol Chem; 1990 Jul; 265(20):11982-9. PubMed ID: 1973167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of a compound heterozygous patient with congenital factor X deficiency and regular replacement therapy with a prothrombin complex concentrate.
    Togashi T; Nagaya S; Nagasawa M; Meguro-Horike M; Nogami K; Imai Y; Kuzasa K; Sekiya A; Horike SI; Asakura H; Morishita E
    Int J Hematol; 2020 Jan; 111(1):51-56. PubMed ID: 31667683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel Ala275Val mutation in factor X gene influences its structural compatibility and impairs intracellular trafficking and coagulant activity.
    Sun N; Chen Y; Peng H; Luo Y; Zhang G
    Thromb Res; 2016 Feb; 138():108-113. PubMed ID: 26708756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A family with factor X deficiency from Argentina: a compound heterozygosis because of the combination of a new mutation (Gln138Arg) with an already known one (Glu350Lys).
    Girolami A; Molina MA; Galletti ML; Ferrari S; Sambado L; Guglielmone H
    Blood Coagul Fibrinolysis; 2016 Sep; 27(6):732-6. PubMed ID: 27031279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Compound Heterozygosis of Two Novel Mutations Causes Factor X Deficiency in a Chinese Pedigree.
    Lu S; Lin W; Ji H; Su M; Zhao X; Wang C
    Acta Haematol; 2021; 144(2):176-181. PubMed ID: 32599596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular defects in the factor X gene caused by novel heterozygous mutations IVS5+1G>A and Asp409del.
    Zhou JW; Liang Q; Chen Q; Xie Y; Ding QL; Wang XF; Xi XD; Wang HL
    Haemophilia; 2013 Jan; 19(1):94-9. PubMed ID: 22931370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.
    Girolami A; Ruzzon E; Tezza F; Scandellari R; Scapin M; Scarparo P
    Haemophilia; 2008 Mar; 14(2):323-8. PubMed ID: 18081833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A recurrent Gly43Asp substitution in coagulation Factor X rigidifies its catalytic pocket and impairs catalytic activity and intracellular trafficking.
    Menegatti M; Vangone A; Palla R; Milano G; Cavallo L; Oliva R; De Cristofaro R; Peyvandi F
    Thromb Res; 2014 Mar; 133(3):481-7. PubMed ID: 24393662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unexplained discrepancies in the activity--antigen ratio in congenital FX deficiencies with defects in the catalytic domain.
    Girolami A; Scarparo P; Vettore S; Candeo N; Scandellari R; Lombardi AM
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):621-7. PubMed ID: 19666942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency.
    Chikasawa Y; Shinozawa K; Amano K; Ogata K; Hagiwara T; Suzuki T; Inaba H; Fukutake K
    Int J Hematol; 2014 Oct; 100(4):345-52. PubMed ID: 25064371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a Missense Mutation in the Catalytic Domain and a Splicing Mutation of Coagulation Factor X Compound Heterozygous in a Chinese Pedigree.
    Feng Y; Ma J; Tang LV; Lin W; Tao Y; Cheng Z; Hu Y
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X.
    Tai SJ; Herzog RW; Margaritis P; Arruda VR; Chu K; Golden JA; Labosky PA; High KA
    J Thromb Haemost; 2008 Feb; 6(2):339-45. PubMed ID: 18036190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Story of Serum Prothrombin Conversion Accelerator, Proconvertin, Stable Factor, Cothromboplastin, Prothrombin Accelerator or Autoprothrombin I, and Their Subsequent Merging into Factor VII.
    Girolami A; Cosi E; Santarossa C; Ferrari S; Luigia Randi M
    Semin Thromb Hemost; 2015 Jun; 41(4):366-73. PubMed ID: 25973586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor X deficiency and intracranial bleeding: who is at risk?
    Rauch R; Girisch M; Wiegand G; Schroeder W; Hofbeck M; Welisch E; Wulff K
    Haemophilia; 2011 Sep; 17(5):759-63. PubMed ID: 21682820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor X Frankfurt I: molecular and functional characterization of a hereditary factor X deficiency (Gla+25 to Lys).
    Nöbauer-Huhmann IM; Höller W; Krinninger B; Turecek PL; Richter G; Scharrer I; Forberg E; Watzke HH
    Blood Coagul Fibrinolysis; 1998 Mar; 9(2):143-52. PubMed ID: 9622212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of two novel mutations causing factor X deficiency in a Chinese pedigree.
    Wang WB; Fu QH; Zhou RF; Wu WM; Ding QL; Hu YQ; Wang XF; Wang HL; Wang ZY
    Haemophilia; 2005 Jan; 11(1):31-7. PubMed ID: 15660986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Disulfide Bond between Cys22 and Cys27 in the Protease Domain Modulate Clotting Activity of Coagulation Factor X.
    Li F; Chen C; Qu SY; Zhao MZ; Xie X; Wu X; Li L; Wang X; Ding Q; Xu Q; Wei DQ; Wu W
    Thromb Haemost; 2019 Jun; 119(6):871-881. PubMed ID: 30919383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.